KFDA to ameliorate biosimilar related rules

Published: 2009-07-23 07:00:00

Updated: 2009-07-23 07:00:00

The Korea Food and Drug Administration has recently unveiled its plan to effectively implement the recently updated biosimilar regulations as part of efforts to promote local biosimilar business.

The drug agency said on July 15 that some of the rules concerning the license of biological produc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK